WHO Announces the Development of Recommendations on New Oral Antibiotics for the Treatment of Gonorrhea
The WHO announced the development of new clinical recommendations for emerging oral antibiotics to treat gonorrhea amid rising global antimicrobial resistance and declining effectiveness of current standard therapies. The focus includes novel agents such as zoliflodacin and gepotidacin, which have shown promising activity against multidrug-resistant Neisseria gonorrhoeae in clinical trials. WHO emphasizes the urgency of updating guidelines as resistance to ceftriaxone-based regimens continues to threaten global gonorrhea control efforts. Clinical implications: This may soon shift practice toward new oral alternatives, potentially simplifying outpatient management while reinforcing the need for ongoing antimicrobial stewardship and susceptibility-guided therapy. Full Access: WHO
Prevalence of Invasive Bacterial Infections Among Febrile Infants Aged 60 to 90 Days – A Systematic Review and Meta-Analysis
This systematic review and meta-analysis evaluated 34,835 well-appearing febrile infants aged 60–90 days from 20 cohorts to determine the prevalence of invasive bacterial infections (IBIs). The pooled prevalence of IBI was 1.11%, with bacteremia accounting for most cases (1.01%) and bacterial meningitis remaining rare (0.11%). Clinical implications: Among well-appearing febrile infants in the third month of life, the risk of bacterial meningitis is very low. These contemporary risk estimates can help guide shared decision-making, risk stratification, and future clinical practice guidelines for managing febrile infants aged 60–90 days. Full Access: JAMA
Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants
The article reports that vaccination during pregnancy leads to a reduction in RSV-associated respiratory illness in early infancy, likely through transplacental antibody transfer. Protection appears most significant in the first months of life, when infants are at highest risk for severe RSV disease. Clinical implications: This reinforces integrating RSV maternal vaccination into prenatal care pathways and supports broader adoption to reduce early infant respiratory illness burden. Full Access: JAMA
CDC Highlights Adverse Outcomes Linked to Travel-Related Cosmetic Procedures
The CDC reports a growing number of severe adverse outcomes, including serious infections, surgical complications, and occasional deaths, associated with cosmetic procedures performed outside the United States. Many cases involve multidrug-resistant organisms or unusual pathogens, delayed recognition of complications, and fragmented post-procedure follow-up once patients return home. Clinical implications clinicians should screen for recent cosmetic procedures during evaluation of febrile illness or wound complications in returning travelers and to consider resistant or atypical infections early. Full Access: CDC